Âé¶¹9191¾«Æ·¹ú²ú

²úÎïÖÐÐÄÄúµÄλÖãºÂé¶¹9191¾«Æ·¹ú²ú > ²úÎïÖÐÐÄ > Ò©Îï±êÆ·£¨Âé¶¹9191¾«Æ·¹ú²ú/°ä¸é°¿£© > ÃâÒßÒÖÖÆ¼Á > ³§°ä³§±õ-527042ÃâÒßÒÖÖÆ¼ÁϵÁÐ

ÃâÒßÒÖÖÆ¼ÁϵÁÐ

¸üÐÂʱ¼ä£º2025-09-17

·ÃÎÊÁ¿£º1831

³§ÉÌÐÔÖÊ£ºÆäËû

Éú²úµØÖ·£º

¼òÒªÃèÊö£º
ÃâÒßÒÖÖÆ¼ÁϵÁÐ
»·æß-ËØ²¹-»å3
Ó¢ÎÄÃûCyclosporine a-d3
²úÎï±àºÅ³§°ä³§±õ-527042
²úÎï·ÖÀàÎȶ¨Í¬Î»Ëرê¼ÇÎï
°ä´¡³§ºÅ222295-76-3
·Ö×Óʽ°ä62±á108¶Ù3±·11°¿12
Æ·ÅÆSCRSTANDARDCAS222295-76-3
·Ö×ÓʽC62H108D3N11O12»õºÅSCSI-527042-5mg
¹æ¸ñ5mg¹©»õÖÜÆÚÏÖ»õ
Ó¦ÓÃÁìÓòÒ½ÁÆÎÀÉú,»¯¹¤,ÉúÎï²úÒµ,ÖÆÒ©/ÉúÎïÖÆÒ©

ÃâÒßÒÖÖÆ¼ÁÊǶԻúÌåµÄÃâÒß·´Ó¦¾ßÓÐÒÖÖÆ×÷ÓõÄÒ©ÎÄÜÒÖÖÆÓëÃâÒß·´Ó¦ÓйØÏ¸°û£¨Tϸ°ûºÍBϸ°ûµÈ¾ÞÊÉϸ°û£©µÄÔöÖ³ºÍ¹¦ÄÜ£¬ÄܽµµÍ¿¹ÌåÃâÒß·´Ó¦¡£ ÃâÒßÒÖÖÆ¼ÁÖ÷ÒªÓÃÓÚÆ÷¹Ù-ÒÆÖ²¿¹ÅųⷴӦºÍ×ÔÉíÃâÒß²¡ÈçÀà·çʪÐԹؽÚÑס¢ºì°ßÀÇ´¯¡¢Æ¤·ôÕæ¾ú²¡¡¢Ä¤ÉöÇòÉöÑס¢Ñ×ÐÔ³¦²¡ºÍ×ÔÉíÃâÒßÐÔÈÜѪƶѪµÈ¡£

³£ÓõÄÃâÒßÒÖÖÆ¼ÁÖ÷ÒªÓÐÎåÀࣺ£¨1£©ÌÇÆ¤Öʼ¤ËØÀ࣬Èç¿ÉµÄ-ËɺÍÇ¿µÄËÉ£»£¨2£©Î¢ÉúÎïÂé¶¹9191¾«Æ·¹ú²ú²úÎÈç»·æß-¾úËØºÍÌÙÃ¹ËØµÈ£»£¨3£©¿¹Âé¶¹9191¾«Æ·¹ú²úÎÈçÁòßò-àÑßʺÍ6-ÛÏ»ùàÑßʵȣ»£¨4£©¶à¿Ë¡ºÍµ¥¿Ë¡¿¹ÁܰÍϸ°û¿¹Ì壬È翹ÁܰÍϸ°ûÇòµ°°×ºÍ°¿°­°Õ3µÈ£»£¨5£©Í黯¼ÁÀ࣬Èç»·Á×-õ£°·µÈ¡£
¸ù¾ÝºÏ³É·½·¨£¬ÃâÒßÒÖÖÆ¼Á´óÖ¿ɷÖΪ£º
£¨1£©Î¢ÉúÎï½Í½â²úÎ»·æß-¾úËØCsAÀà¡¢Ëû¿Ë-Ī˾Tacrolimus£¨FK506£©¡¢À×ÅÁÃ¹ËØRapamycin£¨RPM£©¼°ÆäÑÜÉúÎïSDZ RAD¡¢Mizoribine£¨MZ£©µÈ£»£¨2£©Íê-È«ÓлúºÏ³ÉÎ´ó²¿·ÖÀ´Ô´ÓÚ¿¹Ö×ÁöÎÖ÷ÒªÓÐÍ黯¼ÁºÍ¿¹Âé¶¹9191¾«Æ·¹ú²úÒ©¶þ´óÀà¡£°üÀ¨¼¤ËØÀࣨÉöÉÏÏÙÆ¤Öʼ¤ËØ¡¢ÌÇÆ¤Öʼ¤ËØ£©¡¢Áòßò-àÑßÊ£¨azathioprine£¬Aza£©¡¢¼×°±-µûßÊ¡¢Leflunomide¡¢breqinar£¨BQR£©µÈ£»£¨3£©°ëºÏ³É»¯ºÏÎRS61443£¨mycophenolate mofetil£¬MMF£©¡¢SDZIMMl25¡¢DeoxysPergualin£¨DSG£¬ÍÑÑõ¾«¹ÏËØ£©µÈ£»£¨4£©ÉúÎïÖÆ¼Á£ºantithymocyte globulin£¨ATG£©¡¢antilymphocyte globulin£¨ALG£©µÈ¡£



ÃâÒßÒÖÖÆ¼ÁϵÁÐ

ÃâÒßÒÖÖÆ¼ÁϵÁÐ

»õºÅÖÐÎÄÃûÓ¢ÎÄÃû
»·æß-Ã¹ËØ A

SCSI-527042°Ú2±á3±Õ-»·æß-Ã¹ËØ´¡[2H3]-Cyclosporine A
SCCT-400829°Ú2±á4±Õ-»·æß-Ã¹ËØ´¡[2H4]-Cyclosporin A
SCSI-511678°Ú2±á12±Õ-»·æß-Ã¹ËØ´¡[2H12]-Cyclosporin A
SCSI-402792°Ú13°ä2,2±á4±Õ-»·æß-Ã¹ËØ´¡´×ËáÑÎ[13C2,2H4]-Cyclosporin A Acetate
SCYJ-505622°Ú2±á4±Õ-»·æß-Ã¹ËØ´¡´×ËáÑÎ[2H4]-Cyclosporin A Acetate
SCSI-503005°Ú2±á4±Õ-ÍÑÇâ»·-æßÃ¹ËØ´¡[2H4]-Dehydro Cyclosporin A
Ëû¿Ë-Ī˾

SCSI-401049[13C, 2H2]-Ëû¿Ë-Ī˾[13C,2H2]-Tacrolimus
SCCT-400185°Ú13°ä,2±á4±Õ-Ëû¿Ë-Ī˾[13C,2H4]-Tacrolimus
À×ÅÁÃ¹ËØ(Î÷ÂÞ-Ī˾)

SCMR-412766°Ú2±á3±Õ-À×ÅÁÃ¹ËØ[2H3]-Rapamycin
SCSI-512840°Ú13°ä,2±á3±Õ-Î÷ÂÞ-Ī˾[13C,2H3]-Sirolimus
SCSI-400857°Ú2±á3±Õ-Î÷ÂÞ-Ī˾֬»¯Îï[2H3]-Temsirolimus
SCSI-316760°Ú2±á7±Õ-Î÷ÂÞ-Ī˾֬»¯Îï[2H7]-Temsirolimus
SCSI-512500°Ú13°ä3,2±á7±Õ-Î÷ÂÞ-Ī˾֬»¯Îï[13C3,2H7]-Temsirolimus
ÒÀάĪ˾

SCMR-407318°Ú2±á4±Õ-ÒÀάĪ˾[2H4]-Everolimus
SCSI-512614°Ú13°ä2,2±á4±Õ-ÒÀάĪ˾[13C2,2H4]-Everolimus
ù·ÓËá

SCSI-400331°Ú2±á3±Õ-ù·ÓËá[2H3]-Mycophenolic acid
SCSI-400889°Ú2±á3±Õ-ù·ÓËá ¦Â-D-ÆÏÌÇÜÕËá[2H3]-Mycophenolic Acid ¦Â-D-Glucuronide
SCSI-400890°Ú2±á3±Õ-ù·ÓËáõ£»ù-¦Â-D-ÆÏÌÇÜÕËá[2H3]-Mycophenolic Acid Acyl-¦Â-D-glucuronide
SCSI-510862°Ú2±á5±Õ-È¥¼×»ùù·ÓËá[2H5]-Demethylmycophenolic acid
SCSI-512926°Ú13°ä,2±á3±Õ-ù·ÓËá[13C,2H3]-Mycophenolic acid
SCSI-512924°Ú13°ä,2±á3±Õ-ù·ÓËá ¦Â-D-ÆÏÌÑÌÇÜÕËá[13C,2H3]-Mycophenolic acid-beta-D-glucuronide
ù·Ó-Ëáõ¥

SCMR-410469°Ú2±á4±Õ-ù·Ó-Ëáõ¥[2H4]-Mycophenolate Mofetil
SCSI-511117°Ú2±á4±Õ-ù·Ó-Ëáõ¥²ÝËáÑÎ[2H4]-Mycophenolate mofetil oxalate
Áòßò-àÑßÊ

SCBD-120139°Ú2±á3±Õ-Áòßò-àÑßÊ[2H3]-Azathioprine
SCSI-401044°Ú13°ä4±Õ-Áòßò-àÑßÊ[13C4]-Azathioprine
»·Á×-õ£°·

SCSI-400921°Ú2±á4±Õ-»·Á×-õ£°·[2H4]-Cyclophosphamide
SCSI-510587°Ú2±á6±Õ-»·Á×-õ£°·[2H6]-Cyclophosphamide
SCCT-401222°Ú2±á8±Õ-»·Á×-õ£°·[2H8]-Cyclophosphamide monohydrate
SCSI-512590°Ú13°ä2,2±á6±Õ-»·Á×-õ£°·[13C2,2H6]-Cyclophosphamide
SCSI-401150°Ú2±á4±Õ-4-¹ýÑõÇâ»·Á×-õ£°·[2H4]-4-Hydroperoxy Cyclophosphamide
SCSI-402417°Ú2±á4±Õ-±·-ÍÑÂÈÒÒ»ù»·Á×-õ£°·[2H4]-N-Dechloroethyl Cyclophosphamide
°×-Ïû°²

SCMR-404579°Ú2±á8±Õ-°×-Ïû°²[2H8]-Busulfan
¼×°±-µûßÊ

SCMR-410007°Ú2±á3±Õ-¼×°±-µûßÊ[2H3]-Methotrexate
SCSI-405075°Ú2±á3±Õ-(¸é)-¼×°±-µûßÊ[2H3]-(R)-Methotrexate
SCSI-403275°Ú2±á3±Õ-¶Ù³¢-¼×°±-µûßʶþ¼ØÑÎ[2H3]-DL-Methotrexate Dipotassium Salt
SCSI-512945°Ú13°ä,2±á3±Õ-¼×°±-µûßÊ[13C,2H3]-Methotrexate

























































³§°ä¸é³§°Õ´¡±·¶Ù´¡¸é¶ÙÊôÓÚÉϺ£Èü¿ÉÈñÆìϽø¿ÚÆ·ÅÆ£¬Îª¿ÆÑй¤×÷ÕßÌṩÓÅÖʲúÎïºÍÕæ³Ï·þÎñ¡£

³§°ä¸é³§°Õ´¡±·¶Ù´¡¸é¶ÙÆ·ÅÆ£¬²úÎïÖÖÀàÆëÈ«£¬Ö÷Òª°üÀ¨ÒÔϼ¸Àࣺ


¡ôÒ©ÎﻯºÏÎï¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï                                        ¡ô°±»ùËá¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï

¡ôÌÇÀ༰ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï                                                   ¡ôάÉúËØ¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï

¡ôÖ¬À༰ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï                                                   ¡ôÈâ¼î¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï

¡ôµ¨Ö­Ëá¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï                                                ¡ô¼¤ËØÀà¹Ì´¼À༰ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï

¡ôÖ²ÎïÌáÈ¡Îï¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï                                         ¡ô¾ÛºÏÎï¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎ°üÀ¨GPC·Ö×ÓÁ¿±êÆ·£¬PEGÑÜÉúÎïµÈ£©

¡ô»·¾³¼ì²â±êÎï¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï                                      ¡ô¹¤Òµ¼ì²â±êÎï¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï

¡ôÅ©²ÐÊ޲мì²â±êÎï¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï                               ¡ô±ê×¼ÈÜÒº¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎɫ¶È±êÒº, AAS, ICP, ICP-MS, ICµÈ±êÒº£©

¡ôʳƷ¼ì²â±êÎï¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï                                      ¡ô»ùÖʼì²â±êÎï¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï


ÁôÑÔ¿ò

  • ²úÎ

  • ÄúµÄµ¥Î»£º

  • ÄúµÄÐÕÃû£º

  • ÁªÏµµç»°£º

  • ³£ÓÃÓÊÏ䣺

  • Ê¡·Ý£º

  • ÏêϸµØÖ·£º

  • ²¹³ä˵Ã÷£º

  • ÑéÖ¤Â룺

    ÇëÊäÈë¼ÆËã½á¹û£¨Ìîд°¢À­²®Êý×Ö£©£¬È磺Èþ¼ÓËÄ=7

Áª
ϵ
ÎÒ
ÃÇ